Ainos, Inc. financial data

Symbol
AIMD, AIMDW on Nasdaq
Industry
Pharmaceutical Preparations
Location
Ainos, Inc., 8880 Rio San Diego Drive Suite 800, San Diego, CA
State of incorporation
TX
Fiscal year end
December 31
Former names
AMARILLO BIOSCIENCES INC (to 3/30/2021)
Latest financial report
10-Q - Q3 2024 - Nov 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 114 % -38.8%
Quick Ratio 4.17 % -86.3%
Debt-to-equity 49.7 % +272%
Return On Assets -50.2 % -78.3%
Operating Margin -14.7K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 13.8M shares -31.8%
Common Stock, Shares, Outstanding 13.8M shares -31.9%
Entity Public Float 5.22M USD
Common Stock, Value, Issued 138K USD -31.9%
Weighted Average Number of Shares Outstanding, Basic 11.3M shares +178%
Weighted Average Number of Shares Outstanding, Diluted 11.3M shares +178%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 93.7K USD -57.8%
Cost of Revenue 184K USD -99.4%
Research and Development Expense 8.32M USD +21%
Operating Income (Loss) -14.9M USD -54.8%
Nonoperating Income (Expense) -1.22M USD -120%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -16.1M USD -24.3%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -16.1M USD -61.7%
Earnings Per Share, Basic -0.33 USD/shares +54.8%
Earnings Per Share, Diluted -0.33 USD/shares +54.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 5.16M USD +117%
Accounts Receivable, after Allowance for Credit Loss, Current 9 USD -99.9%
Inventory, Net 161K USD -26.1%
Other Assets, Current 332K USD
Assets, Current 5.65M USD +85.8%
Property, Plant and Equipment, Net 649K USD -44.1%
Intangible Assets, Net (Excluding Goodwill) 24.9M USD -15.4%
Other Assets, Noncurrent 183K USD -22.1%
Assets 31.4M USD -7.35%
Accounts Payable, Current 109K USD
Contract with Customer, Liability, Current 110K USD
Liabilities, Current 4.13M USD +404%
Operating Lease, Liability, Noncurrent 3.28K USD
Other Liabilities, Noncurrent 217K USD +143%
Liabilities 13.3M USD +116%
Accumulated Other Comprehensive Income (Loss), Net of Tax -244K USD
Retained Earnings (Accumulated Deficit) -48.1M USD -50.5%
Stockholders' Equity Attributable to Parent 18M USD -34.9%
Liabilities and Equity 31.4M USD -7.35%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.49M USD -4.37%
Net Cash Provided by (Used in) Financing Activities 778K USD -2.81%
Net Cash Provided by (Used in) Investing Activities -111K USD -53.5%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 13.8M shares -31.9%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -855K USD -20.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 5.16M USD +117%
Deferred Tax Assets, Valuation Allowance 9.02M USD +21.1%
Payments to Acquire Property, Plant, and Equipment 4.43K USD -93.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -16.1M USD -60.1%
Property, Plant and Equipment, Gross 1.81M USD +7.31%
Operating Lease, Liability, Current 24.2K USD
Deferred Tax Assets, Operating Loss Carryforwards 7.39M USD +14.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50M shares +400%
Additional Paid in Capital 66.2M USD +10.8%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 9.02M USD +20.8%
Share-based Payment Arrangement, Expense 1.75M USD +44.9%
Interest Expense 48.7K USD +425%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%